Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury

Journal of Virology

Volumn 79, Issue 16, 2005, Pages 10730-10739

  Sun, Jiaren ^a   Tumurbaatar, Batbayar ^a   Jia, Junhui ^a   Diao, Hong ^a   Bodola, Francis ^a   Lemon, Stanley M ^a   Tang, Wendell ^a   Bowen, David G ^b   McCaughan, Geoffrey W ^b   Bertolino, Patrick ^b   Chan, Teh Sheng ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; STRUCTURAL PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HOMEOSTASIS; HYDRODYNAMICS; IMMUNOMODULATION; LIVER INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TRANSGENE; TRANSGENIC MOUSE; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEPACIVIRUS; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; TRANSGENES;

ANIMALIA; HEPATITIS C VIRUS; MUS MUSCULUS;

EID: 23244431661     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.16.10730-10739.2005     Document Type: Article

References (67)

1. Abe, K., T. Kurata, Y. Teramoto, J. Shiga, and T. Shikata. 1993. Lack of susceptibility of various primates and woodchucks to hepatitis C virus. J. Med. Primatol. 22:433-434.
2. Anton, M., and F. L. Graham. 1995. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression. J. Virol. 69:4600-4606.
3. Bertolino, P., M. C. Trescol-Biemont, and C. Rabourdin-Combe. 1998. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur. J. Immunol. 28:221-236.
4. Bertolino, P., D. G. Bowen, G. W. McCaughan, and B. Fazekas de St Groth. 2001. Antigen-specific primary activation of CD8+ T cells within the liver. J. Immunol. 166:5430-5438.
5. Reference deleted.
6. Bigger, C. B., K. M. Brasky, and R. E. Lanford. 2001. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 75:7059-7066.
7. Bowen, D. G., A. Warren, T. Davis, M. W. Hoffmann, G. W. McCaughan, B. F. De St Groth, and P. Bertolino. 2002. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells. Gastroenterology 123:1252-1264.
8. Bowen, D. G., M. Zen, L. Holz, T. Davis, G. W. McCaughan, and P. Bertolino. 2004. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity J. Clin. Investig. 114:701-712.
9. Bukh, J. 2001. Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a. J. Viral Hepat. 8:228-231.
10. Burgio, V. L., G. Ballardini, M. Artini, M. Caratozzolo, F. B. Bianchi, and M. Levrero. 1998. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology 27:1600-1606.
11. Carvalho, L. H., J. C. Hafalla, and F. Zavala. 2001. Elispot Assay to Measure Antigen-Specific Murine CD8+ T Cell Responses. J. Immunol. Methods 252:207-218.
12. Cho, H. J., T. Hayashi, S. K. Datta, K. Takabayashi, J. H. Van Uden, A. Homer, M. Corr, and E. Raz. 2002. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J. Immunol. 168:4907-4913.
13. Crispe, I. N. 2003. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3:51-62.
14. Diebold, S. S., M. Montoya, H. Unger, L. Alexopoulou, P. Roy, L. E. Haswell, A. Al-Shamkhani, R. Flavell, P. Borrow, and C. Reis e Sousa. 2003. Viral infection switches non-plasmacytoid dendritic cells into high Interferon producers. Nature 424:324-328.
15. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T Cell help. Science 302:659-662.
16. Gremion, C., B. Grabscheid, B. Wolk, D. Moradpour, J. Reichen, W. Pichler, and A. Cerny. 2004. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-Fasl interaction. J. Virol. 78:2152-2157.
17. Gruener, N. H., F. Lechner, M. C. Jung, H. Diepolder, T. Gerlach, G. Lauer, B. Walker, J. Sullivan, R. Phillips, G. R. Pape, and P. Klenerman. 2001. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 75:5550-5558.
18. Guerder, S., D. E. Picarella, P. S. Linsley, and R. A. Flavell. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91:5138-5142.
19. Guerder, S., E. E. Eynon, and R. A. Flavell. 1998. Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes. J. Immunol. 161:2128-2140.
20. Hayashi, S., and A. P. McMahon. 2002. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244:305-318.
21. Inoue, K., K. Sekiyama, M. Yamada, T. Watanabe, H. Yasuda, and M. Yoshiba. 2003. Combined Interferon alpha2b and cyclosporin a in the treatment of chronic hepatitis C: controlled trial. J. Gastroenterol. 38:567-572.
22. Isom, H. C. 1980. DNA synthesis in isolated hepatocytes infected with herpesviruses. Virology 103:199-216.
23. Jo, D., A. Nashabi, C. Doxsee, Q. Lin, D. Unutmaz, J. Chen, and H. E. Ruley. 2001. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat. Biotechnol. 19:929-933.
24. Kafri, T., D. Morgan, T. Krahl, N. Sarvetnick, L. Sherman, and I. Verma. 1998. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc. Natl. Acad. Sci. USA 95:11377-11382.
25. Kanegae, Y., G. Lee, Y. Sato, M. Tanaka, M. Nakai, T. Sakaki, S. Sugano, and I. Saito. 1995. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:3815-3821.
26. Kantzanou, M., M. Lucas, E. Barnes, H. Komatsu, G. Dusheiko, S. Ward, G. Harcourt, and P. Klenerman. 2003. Viral escape and T cell exhaustion in hepatitis C virus infection analysed using class I peptide tetramers. Immunol. Lett. 85:165-171.
27. + effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J. Immunol. 169:2407-2413.
28. Knodell, R. G., K. G. Ishak, W. C. Black, T. S. Chen, R. Craig, N. Kaplowitz, T. W. Kiernan, and J. Wollman. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
29. Lanford, R. E., C. Bigger, S. Basset, and G. Klimpel. 2001. The chimpanzee model of hepatitis C virus infections. ILAR J. 42:117-126.
30. Le, Y., S. Gagneten, D. Tombaccini, B. Bethke, and B. Sauer. 1999. Nuclear targeting determinants of the phage P1 Cre DNA recombinase. Nucleic Acids Res. 27:4703-4709.
31. Le Bon, A., N. Etchart, C. Rossmann, M. Ashton, S. Hou, D. Gewert, P. Borrow, and D. F. Tough. 2003. Cross-priming of CD8+ T cells stimulated by virus-induced type 1 interferon. Nat. Immunol. 4:1009-1015.
32. Lerat, H., M. Honda, M. R. Beard, K. Loesch, J. Sun, Y. Yang, M. Okuda, R. Gosert, S. Y. Xiao, S. A. Weinman, and S. M. Lemon. 2002. Steatosis and liver cancerin transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122:352-365.
33. Liu, F., Y. Song, and D. Liu. 1999. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6:1258-1266.
34. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520.
35. Mehal, W. Z., A. E. Juedes, and I. N. Crispe. 1999. Selective retention of activated Cd8+ T cells by the normal liver. J. Immunol. 163:3202-3210.
36. Mehal, W. Z., F. Azzaroli, and I. N. Crispe. 2001. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J. Immunol. 167:667-673.
37. Mochizuki, K., N. Hayashi, K. Katayama, N. Hiramatsu, T. Kanto, E. Mita, T. Tatsumi, N. Kuzushita, A. Kasahara, H. Fusamoto, T. Yokochi, and T. Kamada. 1997. B7/Bb-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C. Hepatology 25:713-718.
38. Moriya, K., H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura, and K. Koike. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4:1065-1067.
39. Muir, A. J., J. D. Bornstein, and P. G. Killenberg. 2004. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-hispanic whites. N. Engl. J. Med. 350:2265-2271.
40. lo thymocytes in vivo. Science 250:1720-1723.
41. Nelson, D. R., G. Y. Lauwers, J. Y. Lau, and G. L. Davis. 2000. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 118:655-660.
42. Ohta, A., M. Sekimoto, M. Sato, T. Koda, S.-i. Nishimura, Y. Iwakura, K. Sekikawa, and T. Nishimura. 2000. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen. J. Immunol. 165:955-961.
43. Peitz, M., K. Pfannkuche, K. Rajewsky, and F. Edenhofer. 2002. Ability of the hydrophobic Fgf and basic tat peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. USA 99:4489-4494.
44. Robertson, J. M., P. E. Jensen, and B. D. Evavold. 2000. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 164:4706-4712.
45. Sauer, B., and N. Henderson. 1988. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85:5166-5170.
46. Sauer, B., and N. Henderson. 1989. Cre-stimulated recombination at LoxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res. 17:147-161.
47. Sauer, B., and N. Henderson. 1990. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol. 2:441-449.
48. Savulescu, J. 2001. Harm, ethics committees and the gene therapy death. J. Med. Ethics 27:148-150.
49. Shata, M. T., D. D. Anthony, N. L. Carlson, L. Andrus, B. Brotman, N. Tricoche, P. McCormack, and A. Prince. 2002. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees. J. Viral Hepat. 9:400-410.
50. Shoukry, N. H., A. Grakoui, M. Houghton, D. Y. Chien, J. Ghrayeb, K. A. Reimann, and C. M. Walker. 2003. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197:1645-1655.
51. Soriano, P. 1999. Generalized LacZ expression with the Rosa26 Cre reporter strain. Nat. Genet. 21:70-71.
52. Sparer, T. E., S. G. Wynn, D. J. Clark, J. M. Kaplan, L. M. Cardoza, S. C. Wadsworth, A. E. Smith, and L. R. Gooding. 1997. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. J. Virol. 71:2277-2284.
53. Su, A. I., J. P. Pezacki, L. Wodicka, A. D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R. H. Purcell, P. G. Schultz, and F. V. Chisari. 2002. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 99:15669-15674.
54. Sun, J., B. Dirden-Kramer, K. Ito, P. B. Ernst, and N. Van Houten. 1999. Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol. 162:5868-5875.
55. Sun, J. R., F. Bodola, X. G. Fan, H. Irshad, L. Soong, S. M. Lemon, and T. S. Chan. 2001. Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J. Virol. 75:11992-11998.
56. Sun, J. R., K. Li, M. T. Shata, and T. Chan. 2004. The immunologic basis for hepatitis C infection. Curr. Opin. Gastroenterol. 20:598-602.
57. Tannour-Louet, M., A. Porten, S. Vaulont, A. Kahn, and M. Vasseur-Cognet. 2002. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver. Hepatology 35:1072-1081.
58. Thimme, R., D. Oldach, K. M. Chang, C. Steiger, S. C. Ray, and F. V. Chisari. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194:1395-1406.
59. Thimme, R., J. Bukh, H. C. Spangenberg, S. Wieland, J. Pemberton, C. Steiger, S. Govindarajan, R. H. Purcell, and F. V. Chisari. 2002. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. USA 99:15661-15668.
60. Tsai, S. L., Y. F. Liaw, M. H. Chen, C. Y. Huang, and G. C. Kuo. 1997. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25:449-458.
61. von Herrath, M. G., S. Guerder, H. Lewicki, R. A. Flavell, and M. B. Oldstone. 1995. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727-738.
62. Wakita, T., C. Taya, A. Katsume, J. Kato, H. Yonekawa, Y. Kanegae, I. Saito, Y. Hayashi, M. Koike, and M. Kohara. 1998. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/LoxP system. J. Biol. Chem. 273:9001-9006.
63. Wakita, T., A. Katsume, J. Kato, C. Taya, H. Yonekawa, Y. Kanegae, I. Saito, Y. Hayashi, M. Koike, M. Miyamoto, Y. Hiasa, and M. Kohara. 2000. Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/Loxp system. J. Med. Virol. 62:308-317.
64. 63a. World Health Organization. 2000. Fact sheet 164. World Health Organization, Geneva, Switzerland.
65. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. Mhc class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytcs in mice infected with El-deleted recombinant adenoviruses. Immunity 1:433-442.
66. Zeuzem, S., and V. Carreno. 2001. Interleukin-12 in the treatment of chronic hepatitis B and C. Antiviral Res. 52:181-188.
67. Zhang, G., Y. K. Song, and D. Liu. 2000. Long-term expression of human alpha 1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure. Gene Ther. 7:1344-1349.